53207-08-2

Basic information

• Product Name: 4-bromo-1,2-diethoxybenzene
• Synonyms: 4-bromo-1,2-diethoxybenzene
• CAS NO: 53207-08-2
• Molecular Formula: C₁₀H₁₃BrO₂
• Molecular Weight: 245.11302
• Mol File: 53207-08-2.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-bromo-1,2-diethoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-1,2-diethoxybenzene(53207-08-2)
• EPA Substance Registry System: 4-bromo-1,2-diethoxybenzene(53207-08-2)

Safety Data

• Hazardous Substances Data: 53207-08-2(Hazardous Substances Data)

Upstream product

• 2050-46-6 1,2-diethoxybenzene 
• 64-67-5 diethyl sulfate 
• 17345-77-6 1-bromo-3,4-dihydroxybenzene 
• 74-96-4 ethyl bromide 
• 75-03-6 ethyl iodide 

Downstream Products

• 1005009-95-9 2-(3,4-diethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 279262-08-7 3,4-diethoxyphenylboronic acid 
• 6298-46-0 N-(3,4-diethoxyphenylacetyl)-β-(3,4-diethoxyphenyl)ethylamine 
• 911-60-4 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinoline hydrochloride 
• 38464-04-9 3,4-diethoxy-phenyl-acetic acid 
• 526190-09-0 2-(3,4-diethoxyphenyl)acetamide 
• 61381-04-2 2-(3,4-diethoxyphenyl)ethylamine 
• 853152-57-5 1-(2-bromo-4,5-diethoxyphenyl)-1-ethanone 
• 95281-48-4 (2-bromo-4,5-diethoxy-phenyl)-phenyl-methanone 
• 96582-53-5 4,5,4',5'-Tetraaethoxy-2,2'-dibenzoyl-biphenyl 
• 93653-31-7 6-Brom-3,4-diethoxy-diphenylmethan 

Relevant articles and documents

Boron Containing PDE4 Inhibitors

The present invention relates to boron containing compounds of Formula (I) [in-line-formulae]X—Y—Z?? Formula (I)[/in-line-formulae] that inhibit phosphodiesterase 4 (PDE4). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders ameliorated by inhibition of PDE4.

NEW AZIRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new azetidine derivatives of the formula (I) wherein Ar1, Ar2, X, R, T and L are as defined in the description, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES

The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c] quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H- imidazo[4,5-c] quinofinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c] quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H- imidazo[4,5-c] quinolinone derivatives; and a process for the preparation of the novel 1H- imidazo[4,5-c] quinolinone derivatives.